Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Debt-to-equity ratio
5Y CAGR
-34.7%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.14 | -99.3% |
| 2024 | 18.24 | +962.3% |
| 2023 | -2.11 | +30.7% |
| 2022 | -3.05 | -403.3% |
| 2021 | 1.01 | -12.4% |
| 2020 | 1.15 | +70.2% |
| 2019 | 0.67 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.00 | -95.5% |
| 2016 | 0.06 | - |